Berberine has been called natures Ozempic. Thats a pretty big promise for an over-the-counter herbal supplement to deliver
Two 2025 meta-analyses, which pool data from multiple studies one covering 50 trials and a second covering 48 found little evidence that GLP-1 drugs either raise or lower cancer risk
Coverage depends on the date, your plan type, and employer decisions: From October 1, 2026: Zepbound returns as a preferred option on standard commercial formularies, covered with standard prior authorization Through September 30, 2026: most commercial plans (Standard, Advanced Control) still exclude Zepbound (excluded July 1, 2025) Self-funded employer plans can override thisyour employer may have kept coverage CVS also removed OSA (sleep apnea) coverage in 2025
Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the Swedish Obese Subjects study
Therefore we examined the ability of P5 to induce recruitment of -arrestin 1 and -2 using a cellular assay that monitors the direct interaction between -arrestin and the receptor
